Enterprise Value

-173.2M

Cash

314.1M

Avg Qtr Burn

-11.59M

Short % of Float

3.72%

Insider Ownership

13.63%

Institutional Own.

87.85%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date